leisure time -WSS

leisure time

author：entertainment 2025-10-02 10:48:55 - browse：495

A medical device to treat below-the-knee chronic limb-threatening ischemia, Esprit BTK resorbable scaffold, is shown consisted of pieces of geometric shapes that lined up into a pipe on a blue background — health tech coverage from STAT — Cardiovascular doctors are optimistic about Abbott’s new below-knee stent that disappears into the blood vessel’s walls over the course of three years. Courtesy Abbott

An Abbott device that failed in heart disease patients is getting a new life in patients with severe vascular disease.

The device is a below-knee stent that widens clogged blood vessels, and then vanishes into the vessel’s walls over the course of three years. It also delivers a drug that prevents scar tissue from forming — a common risk factor with traditional metal stents that further narrow the vessel.

Abbott’s first dissolvable stent, for coronary artery disease, received Food and Drug Administration approval in 2016. But the company voluntarily pulled the product from the market just over a year later due to “low commercial uptake.” The device also received mixed results in clinical trials.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Duchenne patients, backed by ‘dark money’ group, to debate drug prices

explore

WSS

With fresh data, a dynamic duo powers Eli Lilly to new heights

Why Titanic fascinates society, still drawing tours to the wreckage

Australia's humpback populations rebound raising hopes of marine scientists

Make 'food is medicine' a key part of White House nutrition meeting

New case study details death in closely watched Alzhiemer's trial

How redistricting in 6 states could affect who controls Congress

focus

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

knowledge

State Dept. review finds Biden bears some blame for Afghanistan failures

Sen. Bill Cassidy on how to lower drug prices

ChatGPT in medicine: STAT answers readers' burning questions

Did the public have the right to know Arthur Ashe had AIDS?

Apple is now the first public company to be valued at $3 trillion

Australia's humpback populations rebound raising hopes of marine scientists

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Option Care buys Amedisys in $3.6 billion home care deal

How one medical school became remarkably diverse

UPS workers' union leader explains what's at stake as strike edges closer

focus

A new study asks: Are we harming blood donors by taking blood?

Kansas must stop changing trans people's sex listing on driver's licenses, judge says

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

UPS workers' union leader explains what's at stake as strike edges closer

The PBM ad wars are taking over Washington, D.C.

Option Care buys Amedisys in $3.6 billion home care deal

explore

leisure time

Wikipedia

hotspot